Find in Library

301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC

oleh: Ivan Chan, Laura Lim, Irene Scarfò, Darrian Moskowitz, Beatriz Millare, Kevin Dang, Jeremy Chen, Nickolas Attanasio, Angela Boroughs, Michelle Nguyen, Suchismita Mohanty, Jenessa Smith, James Zhang, Jennifer McDevitt, Thomas J Gardner, Alma Gomez, Vince Thomas, Marvin Chew, Rakesh Sudhakah, Amanda Fearon, Vibhavari Sail, Stanley Zhou